Nxera Pharma Co Forecast, price target & analysts
Nxera Pharma Co Target price 2026 - Analyst rating & recommendation
Nxera Pharma Co Classifications & Recommendation
Nxera Pharma Co Price Target
| Target Price | ¥1,887.00 |
| Price | ¥1,234.00 |
| Potential |
52.92%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Nxera Pharma Co 2027 .
The average Nxera Pharma Co target price is ¥1,887.00.
This is
52.92%
register free of charge
¥4,725.00
282.90%
register free of charge
¥1,010.00
18.15%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Nxera Pharma Co to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Nxera Pharma Co stock has an average upside potential 2027 of
52.92%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 29.62 | 40.54 |
| 2.71% | 36.90% | |
| EBITDA Margin | -18.41% | 26.69% |
| 50.25% | 244.98% | |
| Net Margin | -42.31% | 13.97% |
| 152.17% | 133.02% |
8 Analysts have issued a sales forecast Nxera Pharma Co 2026 . The average Nxera Pharma Co sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Nxera Pharma Co EBITDA forecast 2026. The average Nxera Pharma Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Nxera Pharma Co Analysts have issued a net profit forecast 2026. The average Nxera Pharma Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | -138.80 | 61.98 |
| 157.42% | 144.65% | |
| P/E | 19.68 | |
| EV/Sales | 3.79 |
9 Analysts have issued a Nxera Pharma Co forecast for earnings per share. The average Nxera Pharma Co EPS is
This results in the following potential growth metrics and future valuations:
Nxera Pharma Co...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
